A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.

MLA

Akbulut, Ozge, et al. “A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.” Molecular Cancer Therapeutics, vol. 19, no. 6, June 2020, pp. 1243–54. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-19-0957.

APA

Akbulut, O., Lengerli, D., Saatci, O., Duman, E., Seker, U. O. S., Isik, A., Akyol, A., Caliskan, B., Banoglu, E., & Sahin, O. (2020). A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Molecular Cancer Therapeutics, 19(6), 1243–1254. https://doi.org/10.1158/1535-7163.MCT-19-0957

Chicago

Akbulut, Ozge, Deniz Lengerli, Ozge Saatci, Elif Duman, Urartu O S Seker, Aynur Isik, Aytekin Akyol, Burcu Caliskan, Erden Banoglu, and Ozgur Sahin. 2020. “A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.” Molecular Cancer Therapeutics 19 (6): 1243–54. doi:10.1158/1535-7163.MCT-19-0957.